Report Categories
View AllRecent Articles
View All
Vertex Pharmaceuticals VRTX FDA ALYFTREK Label Expansion Reinforces Core Cystic Fibrosis Franchise Amid Broader Pipeline Diversification Push
IMVT Immunovant beats earnings estimates by 16 but stock slides 5 as investors await revenue clarity
CRANR CraneHbr Rts quarterly earnings data unavailable leadership to share growth outlook in upcoming investor briefing
BDJ BlackrockDiv maintains quarterly dividend commitment while navigating equity market dynamics CEO reaffirms incomefocused strategy